EI
TWST icon

EAM Investors’s Twist Bioscience TWST Stock Holding History

EAM Investors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.44M Buy
+62,564
New +$4.07M 0.57% 50
2024
Q3 		– Sell
-64,764
Closed -$3.19M – 331
2024
Q2 		$3.19M Buy
+64,764
New +$2.64M 0.52% 105
2021
Q1 		– Sell
-15,678
Closed -$2.21M – 443
2020
Q4 		$2.21M Sell
15,678
-6,312
-29% -$700K 0.36% 89
2020
Q3 		$1.67M Buy
+21,990
New +$1.37M 0.4% 84

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

EAM Investors's TWST Position: Q2 2026 in Review

EAM Investors opened a new position in Twist Bioscience (TWST) in Q2 2026: 62,564 shares worth $6.44M. The stake represents 0.57% of the portfolio and ranks #50 among its holdings. This is a return to the name: EAM Investors previously reported a position in TWST as recently as Q2 2024.

EAM Investors first reported a position in TWST in Q3 2020 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • EAM Investors held 62,564 shares of Twist Bioscience worth $6.44M as of Q2 2026.
  • Twist Bioscience was a new EAM Investors position in Q2 2026.
  • Twist Bioscience made up 0.57% of EAM Investors's portfolio in Q2 2026, its #50 holding.
  • EAM Investors first reported a position in Twist Bioscience in Q3 2020 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.